Immunic (IMUX) Preferred Dividend Payments (2013 - 2014)
Immunic (IMUX) posted Preferred Dividend Payments of $4.7 million for Q2 2014, up 54.92% sequentially from $3.0 million in Q1 2014, and up 323.5% YoY from $1.1 million in Q2 2013.
Powered by 
Analysis
Immunic (IMUX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Immunic has reported Preferred Dividend Payments for 2 years, with the latest figure at $4.7 million in Q2 2014.
- Quarterly Preferred Dividend Payments rose 323.5% year-over-year to $4.7 million in Q2 2014, while the trailing twelve-month figure through Sep 2015 was $4.7 million (up 27.55% YoY) and the FY2014 annual result came in at $4.4 million, up 6790.62% from the prior year.
- Preferred Dividend Payments rose to $4.7 million in Q2 2014 per IMUX's latest filing, from $3.0 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $4.7 million in Q2 2014 and troughed at -$4.1 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Immunic | 546.30 Mn | 546.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2014 | 4.72 Mn |
| Mar 31, 2014 | 3.05 Mn |
| Dec 31, 2013 | 2.17 Mn |
| Sep 30, 2013 | 2.05 Mn |
| Jun 30, 2013 | 1.12 Mn |
| Mar 31, 2013 | 970,000.00 |